Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kajaste-Rudnitski

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Gene Therapy|July 15, 2020
Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineeringFrancesco Piras, Anna Kajaste-Rudnitski
The Journal of Experimental Medicine|December 6, 2024
Antiviral immunity lassoed down by excess RNAErika Valeri, Anna Kajaste-Rudnitski
Human Gene Therapy|March 27, 2015
Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cellsAnna Kajaste-Rudnitski, Luigi Naldini
Methods in Molecular Biology (Clifton, N.J.)|August 7, 2013
Lipid-based nanoparticles as nonviral gene delivery vectorsDaniele Pezzoli, Anna Kajaste-Rudnitski, Roberto Chiesa, et al.
STAR Protocols|March 7, 2023
Protocol to differentiate monolayer human induced pluripotent stem cells into inflammatory responsive astrocytesAnna Maria Sole Giordano, Monah Abou Alezz, Ivan Merelli, et al.
Amino Acids|November 28, 2009
Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22Anna Kajaste-Rudnitski, Cinzia Pultrone, Flavia Marzetta, et al.
The Journal of Biological Chemistry|December 24, 2005
The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cellsAnna Kajaste-Rudnitski, Tomoji Mashimo, Marie-Pascale Frenkiel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2014
Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cellsCarolina Petrillo, Daniela Cesana, Francesco Piras, et al.
Journal of Virology|February 15, 2013
TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradationAndrea Di Pietro, Anna Kajaste-Rudnitski, Alexandra Oteiza, et al.
Human Gene Therapy|September 6, 2023
Understanding and Tackling Immune Responses to Adeno-Associated Viral VectorsHelena Costa-Verdera, Carmen Unzu, Erika Valeri, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Gene Therapy|July 15, 2020
Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineeringFrancesco Piras, Anna Kajaste-Rudnitski
The Journal of Experimental Medicine|December 6, 2024
Antiviral immunity lassoed down by excess RNAErika Valeri, Anna Kajaste-Rudnitski
Human Gene Therapy|March 27, 2015
Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cellsAnna Kajaste-Rudnitski, Luigi Naldini
Methods in Molecular Biology (Clifton, N.J.)|August 7, 2013
Lipid-based nanoparticles as nonviral gene delivery vectorsDaniele Pezzoli, Anna Kajaste-Rudnitski, Roberto Chiesa, et al.
STAR Protocols|March 7, 2023
Protocol to differentiate monolayer human induced pluripotent stem cells into inflammatory responsive astrocytesAnna Maria Sole Giordano, Monah Abou Alezz, Ivan Merelli, et al.
Amino Acids|November 28, 2009
Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22Anna Kajaste-Rudnitski, Cinzia Pultrone, Flavia Marzetta, et al.
The Journal of Biological Chemistry|December 24, 2005
The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cellsAnna Kajaste-Rudnitski, Tomoji Mashimo, Marie-Pascale Frenkiel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2014
Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cellsCarolina Petrillo, Daniela Cesana, Francesco Piras, et al.
Journal of Virology|February 15, 2013
TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradationAndrea Di Pietro, Anna Kajaste-Rudnitski, Alexandra Oteiza, et al.
Human Gene Therapy|September 6, 2023
Understanding and Tackling Immune Responses to Adeno-Associated Viral VectorsHelena Costa-Verdera, Carmen Unzu, Erika Valeri, et al.
Pageof 5